Expert Recaps Immunotherapy Milestones in NSCLC – OncLive
OncLive |
Expert Recaps Immunotherapy Milestones in NSCLC
OncLive What are some other combination regimens that are showing promise? As for other combinations being developed with immunotherapy, the one that is furthest in development is the trial of carboplatin, paclitaxel, and bevacizumab alone or with atezolizumab … |
